IP Library Patent Application 14290527
Patent Application
App. No. 14/290,527

Dual Variable Domain Immunoglobulin and Uses Thereof

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/290,527
Abstract

The present invention relates to engineered multivalent and multispecific binding proteins, methods of making, and specifically to their uses in the prevention and/or treatment of acute and chronic inflammatory and other diseases.

Claims (19)

1 - 51 . (canceled)

52 . An isolated nucleic acid encoding an amino acid sequence of at least one of two polypeptide chains that form a binding protein, wherein said at least one polypeptide chain is:

(a) a first polypeptide chain of said binding protein that comprises formula 1: VD1-(X1)n-VD2-C-(X2)n, wherein VD1 is a first heavy chain variable domain, VD2 is a second heavy chain variable domain, C is a heavy chain constant domain, X1 is a linker with the proviso that it is not CH1, X2 is an Fc region, and n is 0 or 1; or

(b) a second polypeptide chain of said binding protein that comprises formula 2: VD1-(X1)n-VD2-C-(X2)n, wherein VD1 is a first light chain variable domain, VD2 is a second light chain variable domain, C is a light chain constant domain, X1 is a linker with the proviso that it is not CH1, X2 does not comprise an Fc region, and n is 0 or 1;

wherein said first polypeptide chain and said second polypeptide chain of said binding protein form two antigen binding sites.

53 . A vector comprising an isolated nucleic acid according to claim 52 .

54 . The vector of claim 53 wherein said vector is selected from the group consisting of pcDNA, pTT, pTT3, pEFBOS, pBV, pJV, pcDNA3.1 TOPO, pEF6 TOPO, and pBJ.

55 . A host cell comprising a vector according to claim 53 .

56 . The host cell according to claim 55 , wherein said host cell is a prokaryotic cell.

57 . The host cell according to claim 56 , wherein said host cell is E. coli.

58 . The host cell according to claim 55 , wherein said host cell is a eukaryotic cell.

59 . The host cell according to claim 58 , wherein said eukaryotic cell is selected from the group consisting of protist cell, animal cell, plant cell, and fungal cell.

60 . The host cell according to claim 58 , wherein said eukaryotic cell is an animal cell selected from the group consisting of: a mammalian cell, an avian cell, and an insect cell.

61 . The host cell according to claim 58 , wherein said host cell is a CHO cell.

62 . The host cell according to claim 58 , wherein said host cell is a COS cell.

63 . The host cell according to claim 58 , wherein said host cell is a yeast cell.

64 . The host cell according to claim 63 , wherein said yeast cell is Saccharomyces cerevisiae.

65 . The host cell according to claim 58 , wherein said host cell is an insect Sf9 cell.

66 - 76 . (canceled)

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2014
From: WU, CHENGBIN; GHAYUR, TARIQ; DIXON, RICHARD W.; SALFELD, JOCHEN G.
To: ABBOTT LABORATORIES
Reel/Frame 033393/0076 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2014
From: ABBOTT LABORATORIES
To: ABBVIE INC.
Reel/Frame 033393/0123 →